APTO - Aptose Biosciences Inc.
IEX Last Trade
0.2115
0.000 0.142%
Share volume: 695,807
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.21
-0.01
-0.04%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2023-08-10 | 2023-11-09 | 2024-11-09 | 2024-05-14 | 2024-08-08 | 2024-11-09 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 14.096 M | 14.452 M | 11.681 M | 12.127 M | 9.760 M | 7.345 M | 6.965 M | |
| Selling general and admin | 5.285 M | 3.870 M | 3.425 M | 3.011 M | 3.315 M | 2.932 M | 2.263 M | |
| Research and development | 8.811 M | 10.582 M | 8.256 M | 9.116 M | 6.445 M | 4.413 M | 4.702 M | |
| Total expenses | 14.096 M | 14.452 M | 11.681 M | 12.127 M | 9.760 M | 7.345 M | 6.965 M | |
| 2.53% | -19.17% | 3.82% | -19.52% | -24.74% | -5.17% | |||
| Operating income | -14.096 M | -14.452 M | -11.681 M | -12.127 M | -9.760 M | -7.345 M | -6.965 M | |
| Ebit | -14.098 M | -14.455 M | -11.679 M | -12.126 M | -9.761 M | -7.345 M | -6.965 M | |
| Pretax income | -13.676 M | -14.129 M | -11.447 M | -11.955 M | -9.640 M | -7.252 M | -6.953 M | |
| 3.31% | -18.98% | 4.44% | -19.36% | -24.77% | -4.12% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -13.676 M | -14.129 M | -11.447 M | -11.955 M | -9.640 M | -7.252 M | -6.953 M | |
| -3.31% | 18.98% | -4.44% | 19.36% | 24.77% | 4.12% |